Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, May 2026 and Jun 2026.
- Largest single sale: $59K (3,000 shares) of Arch Capital Group on Jun 3, 2026. Filing
- Last sale before this period: Jun 14, 2021.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Director | Oct 2, 2025 | Oct 6, 2026 |
| Arch Capital Group (ACGL) | Director | Nov 8, 2010 | Jun 4, 2026 |
| Biogen (BIIB) | Former Director | Jul 24, 2008 | Jan 27, 2023 |
Also a director at
Arch Capital Group (ACGL), Biogen (BIIB) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 2, 2026, Dyne Therapeutics, Inc.: bought 2,500 shares for $40K. 1 filing: 1
- Jun 8, 2026, Dyne Therapeutics, Inc.: bought 2,000 shares for $34K. 1 filing: 1
- Jun 3, 2026, Arch Capital Group: sold 3,000 shares for $59K, no plan disclosed. 1 filing: 1
- Jun 3, 2026, Dyne Therapeutics, Inc.: bought 2,500 shares for $44K. 1 filing: 1
- May 26, 2026, Dyne Therapeutics, Inc.: bought 2,000 shares for $36K. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.